Applying an Ethical Lens to the Treatment of People With Multiple Sclerosis
The practice of neurology requires an understanding of clinical ethics for decision-making. In multiple sclerosis (MS) care, there are a wide range of ethical considerations that may arise. These involve shared decision-making around selection of a disease-modifying therapy (DMT), risks and benefits of well-studied medications in comparison to supplements with limited information, allocation of resources and accessibility to MS care, and disparities in healthcare. We share a series of cases that illustrate ethical issues that may arise in the care of patients with MS. This narrative review articulates relevant ethical theories and frameworks that can be applied to common clinical scenarios in the current practice of MS.
Authors
- Farrah Jasmine Mateen (ORCID: https://orcid.org/0000-0002-4293-8115)
- Methma Udawatta
Institutions
- Northwestern University (US)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Annals of Clinical and Translational Neurology
- Published
- 2025-12-31
- DOI
- https://doi.org/10.1002/acn3.70302
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Alexion Pharmaceuticals
- TG Therapeutics
- Horizon Therapeutics
- Genentech
- EMD Serono